Back to Aberdeen Group plc Aberdeen Group plc

ABVXABVX

Showing 8 of 9 quarters

Position history for Aberdeen Group plcAberdeen Group plc's holdings in Abivax SA

Yes. Aberdeen Group holds 522,025 shares of ABVX (Abivax), worth $69.6M, as of its Q2 2026 13F filing. It increased the position by 90,784 shares (+21.1%) from Q1 2026. Aberdeen Group has held ABVX since Q2 2024, across 9 quarterly 13F filings. ABVX is 0.1% of Aberdeen Group's reported 13F portfolio.

Current Value

$69.6M

Current Shares

522,025

Total Value Change

+$65.9M

Total Shares Change

+205,594

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
522,025
+21.1%
$69.6M0.1%$133.26
35
2026-Q1
Increased
431,241
+1.1%
$48M0.1%$111.10
29
2025-Q4
Decreased
426,658
-45.8%
$57.5M0.1%$134.86
0
2025-Q3
Increased
787,417
+10.8%
$66.9M0.1%$84.90
39
2025-Q2
Unchanged
710,516
0.0%
$5.4M0.0%$7.65
0
2025-Q1
Increased
710,516
+67.5%
$4.4M0.0%$6.25
40
2024-Q4
Increased
424,181
+34.0%
$3.1M0.0%$7.32
34
2024-Q3
Increased
316,431
+167.7%
$3.6M0.0%$11.60
43

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used